Showing 2381-2390 of 2894 results for "".
- New Research Uncovers Breakthrough in Tissue Engineering Using Bacteriahttps://modernaesthetics.com/news/new-research-uncovers-breakthrough-in-tissue-engineering-using-bacteria/2473654/New research from the Technical University of Denmark uncovered new ground in tissue engineering and cell therapy by harnessing the healing power of bacteria. The study was published in the journal Bioactive Materials and details a new biopolymer, Pantoan Methacrylate (PAMA), with muscle regenera
- New Report Dives into How Benefits of Ozempic Are Multiplyinghttps://modernaesthetics.com/news/new-report-dives-into-how-benefits-of-ozempic-are-multiplying/2473652/GLP-1 drugs could offer numerous health benefits beyond diabetes and weight loss, according to recent studies highlighted in an article on Wired.com. Research is bringing to light the other potential uses of the dr
- L’Oréal Eyes Aesthetics Market with Acquisition of Minority Stake in Galdermahttps://modernaesthetics.com/news/loreal-eyes-aesthetics-market-with-acquisition-of-galderma/2473646/Major beauty brand L’Oréal announced the acquisition of a 10% stake in Galderma, a Swiss pharmaceutical company. The two companies have agreed to work towards a strategic scientific partnership that will leverage the undisputed expertise of both companies, according to a press releas
- Signature Facial Experience from Luxury Australian Beauty Brand Now Available in NYChttps://modernaesthetics.com/news/signature-facial-experience-from-luxury-australian-beauty-brand-now-available-in-nyc/2473643/A popular signature facial experience from the Australian luxury beauty brand RATIONALE is now available in New York City. The company launched the RATIONALE Residency at the Equinox Hotel, and private in-home appointments by request, on August 1. Rationale is known for its luxuri
- FDA Issues Warning Over Unapproved Skin Peel Products Sold at Retailershttps://modernaesthetics.com/news/fda-issues-warning-over-unapproved-skin-peel-products-sold-at-retailers/2473642/Several online retailers, including Walmart and Amazon, have received a warning from the US Food and Drug Administration (FDA) for selling unapproved chemical peel skin products. The products are accused of containing corrosive chemicals in high concentrations that are unsafe for use at home with
- Evolus Expands Global Footprint with Introduction of Treatment in Australiahttps://modernaesthetics.com/news/evolus-expands-global-footprint-with-introduction-of-treatment-in-australia/2473641/The performance beauty company, Evolus, has begun operations in Australia with the launch of Nuceiva, a prabotulinumtoxinA. Nuceiva is approved by the Therapeutic Goods Administration (TGA) for the temporary improvement in the appearance of moderate to severe glabella lines in adul
- Dermal Fillers Global Marketing Rising in Demandhttps://modernaesthetics.com/news/dermal-fillers-global-marketing-rising-in-demand/2473640/The dermal fillers global market size is expected to grow from almost $4 billion over the next seven years, reaching an estimated $7.58 billion by 2031. It’s anticipated to register a compound annual growth rate of 8.3% during the forecasted period, according to Premium Market Insights.&nbs
- First, Only US Neurotoxin for Simultaneous Treatment of Upper Facial Lines Gets FDA Approvalhttps://modernaesthetics.com/news/first-only-us-neurotoxin-for-simultaneous-treatment-of-upper-facial-lines-gets-fda-approval/2473638/Merz Aesthetics announced the US Food and Drug Administration approved XEOMIN (incobotulinumtoxinA) as the first and only neurotoxin for the simultaneous treatment of upper facial lines – forehead lines, frown lines, and crow’s feet. XEOMIN was first approved in 2011 f
- Aesthetic Lasers and Energy Devices Market Size to Grow By $2.37Bhttps://modernaesthetics.com/news/aesthetic-lasers-and-energy-devices-market-size-to-grow-by-237b-5/2473637/The global aesthetics laser and energy devices market size is estimated to grow by $2.37 billion from 2024 to 2028. Technavio report the market will grow at a compound annual growth rate of almost 10.87% during the next four years. A key factor driving growth in the market is the
- DefenAge Skincare Launches New Patented Skin Regeneration Technologyhttps://modernaesthetics.com/news/defenage-skincare-launches-new-patented-skin-regeneration-technology/2473630/DefenAge Skincare announced a new skin regeneration technology with the acquisition of a new patent using a regenerative approach for skin care and wound healing. The company says the cutting-edge technology is now available for licensing and product development partnerships, presenting an unpara